drugset / Trial / NCT03263624

Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease

NCT03263624

Phase 4 Unknown 30 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

Nail psoriasis has a high incidence amongst patients with psoriasis.It is estimated to affect 80% of psoriatic patients at some time during their lives and has a significant adverse influence on their quality of life. Treatment of nail psoriasis is disappointing, as it is refractory to treatment, with conventional therapies often having little effect.

Timeline

Start
2017-10-01
Primary completion
2018-10-01
Completion
2018-11-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tazarotene Small molecule 0.1 % Topical

Indications